Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-05-02
2006-05-02
Landsman, Robert S. (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S326000, C530S327000, C530S328000, C530S329000, C530S330000
Reexamination Certificate
active
07037891
ABSTRACT:
The present invention concerns methods for the treatment of metabolic-related diseases by the modulation of GRK associated signal transduction. Preferred in accordance with the invention are modulators which comprise sequences derived from specific regions of the GRK.
REFERENCES:
patent: WO 93/16703 (1993-09-01), None
patent: WO 97/14038 (1997-04-01), None
patent: WO 98/53050 (1998-11-01), None
patent: WO 98/53051 (1998-11-01), None
patent: WO 00/18895 (2000-04-01), None
patent: WO 00/73469 (2000-12-01), None
Alemá et al, “Differentiation of PC12 phaeochromocytoma cells induced by v-src oncogene”,Nature316(6028):557-559 (1985).
Birchall et al, “Ro 32-0432, a Selective and Orally Active Inhibitor of Protein Kinase C Prevents T-Cell Activation”,J Parmacol Exp Ther268(2):922-929 (1994).
Bradshaw et al, “Therapeutic potential of protein kinase C inhibitors”,Agents Actions38(1-2):135-147 (1993).
Dudek et al, “Regulation of neuronal Survival by the Serine-Threonine Protein Kinase Akt”,Science275:661-665 (1997).
Franke et al, “P13K: Downstream AKTion Blocks Apoptosis”,Cell88:435-437 (1997).
Freedman et al, “Desensitization of G Protein-Coupled Receptors”,Recent Prog Horm Res51:319-353 (1996).
Ghiso et al, “Binding of Cystatin C to C4: The Importance of Sense-Antisense Peptides in their Interaction”,Proc Nat Acad Sci USA87(4):1288-1294 (1990).
Glover et al, “Polo-Kinase: The Choreographer of the Mitotic Stage?”,J Cell Biol135:1681-1684 (1996).
Hanks et al, The Eukaryotic Protein Kinase Superfamily inThe Protein Kinase Facts Book,vol. I, Hardie et al, eds., Academic Press, Chapter 2 (1995).
Hemmings BA, “Akt Signaling: Linking Membrane Events to Life and Death Decisions”,Science275:628-631 (1997).
Hubbard et al, “Crystal structure of the tyrosine kinase domain of the human insulin receptor”,Nature372:746-753 (1994).
Kallunki et al. “JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation”,Genes&Development8:2996-3007 (1994).
Kohn et al, Expression of a Constitutitively Active Akt Ser/Thr Kinase in 3T3-L1 Adipocytes Stimulates Glucose Uptake and Glucose Transporter 4 TranslocationJ Biol Chem271(49):31372-31378 (1996).
Lange-Carter et al, “A Divergence in the MAP Kinase Regulatory Network efined by MEK Kinase and Raf”,Science260:315-318 (1993).
Lovrić et al, “Activation of Mil/Raf protein kinases in mitotic cells”,Oncogene12:1109-1116 (1996).
Mason IJ, “Th Ins and Outs of Fibroblast Growth Factors”,Cell78:547-552 (1994).
McMurray et al, “Cyclic peptide substrates of pp60c-src: synthesis and evaluation”,Int J Pept Protein Res42(3):209-215 (1993) (fromChem Abastracts1993, Acc. No. 120:100177).
Mohammadi et al, “Structure of the FGF Receptor Tyrosine Kinase Domain Reveals a Novel Autoinhibitory Mechanism”,Cell86:577=587 (1996).
Nishizuka Y, “Protein kinase C and lipd signaling for sustained cellular responses”,FASEB J9:484-496 (1995).
Okada et al, “Synthesis of Gin-Val-Val-Ala-Gly, a common sequence of thiol proteinase inhibitors, and its derivatives. Relationship between structure and effect on thiol proteinases”,Pept Chem653-656 (1998) (fromChem Abstracts,1998, Acc. No. 109:69322).
Simmons et al, “Identification of an early-growth-response gene encoding a novel putative protein kinase”,Mol Cel Biol12(9):4164-4169 (1992).
Taylor et al, “cAMP-dependent protein kinase defines a family of enzymes”,Phil Trans R Soc Lond B340:315-324 (1993).
Browdy and Neimark PLLC
Children's Medical Center Corporation
Landsman Robert S.
Yissum Research and Development
LandOfFree
Methods of modulating G-protein-coupled receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of modulating G-protein-coupled receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of modulating G-protein-coupled receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3625449